-patients department inclined by 24.6% and 8.9% respectively. Causing the increasing in the total revenue from Gastrointestinal diseases and seasonal diceases such as Nasopharyngitis, Influenza, Dengue Fever

transactions, the segment had a decrease in revenue of 125.69 million baht, mainly resulting from less production in the Philippines and the slowdown in business in Thailand. Main target customers for the

8,930 million baht, showing an increase of 150 million baht or 2% y-y. In second quarter, The Company’s revenues was 4,541 million baht, increasing by 2% y-y and 3% q-q. This is the result of increase in

Expenses The selling expenses for the fiscal year 2018 and 2019 were in amounts of Baht 15.83 million and Baht 18.37 million, increasing by 16.0%. The proportion of selling expenses incurred compared to

Company) of Baht 1,741.26 million or Baht 1.20 per share, increasing by Baht 614.68 million, or 54.6 percent, compared to the profit of Baht 1,126.58 million or Baht 0.78 per share of the 1st quarter of

3Q2016 and 3Q2017 were in amounts of Baht 155.79 million and Baht 127.59 million, respectively, which decreased by 18.0%. There are three main reasons for the decrease in revenue. Firstly, the southern

related transactions, the segment had a decrease in revenue of 89.26 million baht, mainly resulting from less production in the Philippines. Main target customers for the Manufacturing and Selling of

for the 3 rd quarter of 2019 showed the profit (attributable to owners of the Company) of THB 1,364.84 million, decreasing by THB 315.69 million. The main reason was Ratchaburi Power Plants had

million, increasing by Baht 166.07 million or 92.97% from the same previous period of Baht 178.62 million. Due to the full revenue recognition from the business obtained from Chilmatch Co.,Ltd. and its

Construction Products Public Company Limited (“Q-CON”) would like to clarify the main reason that caused operating result for 2017 changed more than 20 percent that of 2016. Q – CON and subsidiary have net